Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2007 / Cilt: 47 - Sayı: 1

Surgical approach to colorectal cancer

Kolorektal kanserli hastalarda cerrahi yaklaşım ve sonuçları

Pages
216–221
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among patients with rectum cancer in 7 patients with Stage C2 and in 1 with Stage B2 tumor radiotherapy was added to the systemic therapy protocol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We investigated 41 patients operated on for colo-rectal cancer in the 5th General Surgery department of Haydarpaşa Numune Education and Research Hospital between December 2003 and December 2006, retrospectively.
📊
Key Findings & Data:Mean age was 62.40 years.
💡
Conclusion & Impact:Among patients with rectum cancer in 7 patients with Stage C2 and in 1 with Stage B2 tumor radiotherapy was added to the systemic therapy protocol.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

We investigated 41 patients operated on for colo-rectal cancer in the 5th General Surgery department of Haydarpaşa Numune Education and Research Hospital between December 2003 and December 2006, retrospectively. Mean age was 62.40 years. The most common complaints at presentation were abdominal pain (39.02%) and weight loss (36.58%). Masses were located in the left colon and rectum in 78.05% of the patients. The most common stage was Stage C2 of Astler Coller with an incidence of 58.55%. Moderately differentiated adenocarcinoma (58.54%) was the most common tumor pathology. In the early postoperative period we reported wound infection in 4 (9.75%) patients and anastamotic leak in 1 (%2.43). Patients were followed once every 3-month-period in the first 2 years and once every 6-month-period in the other 2 years with physical examination, determination of serum carcinoemb-ryonic antigen (CEA) and tests for liver function,ectosigmoidoscopy if rectal resection was performed while chest X-ray and abdominal ultraso-nography were performed once every year. We reported hepatic metastasis in 4 (9.75%) patients, recurrence at the site of anastamosis in 1 (2.43%) and frozen pelvis in 1 (2.43%) at postoperative follow-up. Histopathologic determination of the specimen showed Stage C2 in 24 patients and Stage D in 1 patient. These patients were administered 6 sessions of chemotherapy with 5-Flourouracil (5FU) and folinic acid. Among patients with rectum cancer in 7 patients with Stage C2 and in 1 with Stage B2 tumor radiotherapy was added to the systemic therapy protocol.

Özet

Haydarpaşa Numune Eğitim ve Araştırma Hastanesi ö.Genel Cerrahi Kliniğinde Aralık 2003-Aralık 2006 tarihleri arasında kolorektal kanser nedeniyle öpere edilen 41 hasta retrospektif olarak incelendi. Ortalama yaş 62.40'idi. En sık başvuru şikayeti karın ağrısı ( %39.02) ve kilo kaybıydı (% 36.58 ). Kitlelerin %78.05'i sol kolon ve rektum yerleşimliydi. Aster Coller evrelemesine göre Evre C2 %58.55 oranında en fazla görülen evreydi. Tümör patolojilerinde en fazla orta derecede diferan-siye adenokarsinom görüldü ( %58.54). Postope-ratif dönemde 4 (%9.75) hastada yara yeri infeksi-yonu , 1 (%2.43 ) hastada anastomoz kaçağı görüldü. Hastalar İlk 2 yıl 3 ayda bir, sonraki 2 yıl her 6 ayda bir fizik muayene, karsinoembriyonik antijen (CEA), karaciğer fonksiyon testleri, rektum re-zeksiyonu uygulanmışsa rektosigmoidoskopi, yılda bir akciğer grafisi ve batın ultrasonografisi (USG) takip programına alındı. Postoperatif takiplerde 4 (%9.75 ) hastada karaciğer metastazı , 1(%2.43 ) hastada anastomoz hattında nüks ,1(%2.43) hastada frozen pelvis görüldü. Postoperatif histopatolojik değerlendirme sonucu 24 hasta Evre C2 , 1 hastada Evre D 'idi. Bu hastalar 5 Fluorourasil (5FU ) ve Folinik asit ( FA ) ile 6 kür kemoterapi programına alındı. 7 rektum tümörlü Evre C2 hastanın kemoterapi programına radyoterapi eklendi. Rektum yerleşimli Evre B2 'li bir hasta aynı kemoterapi ve radyoterapi programına alındı.

🔖

Cite This Article

DULUNDU, E., TOPALOĞLU, Ü., KAYAHAN, M., ÖZEL, Y., YARDIMCI, S., ÖZKAN, E. (2022). Surgical approach to colorectal cancer. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 47 - Sayı: 1, 216–221. https://ajindex.com/articles/535572

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Miccini M, Mazzoni G, Cassini D, et al. Colorectal carcinoma in the young. Prognostic factors. G Chir. 2005 Oct; 26(10):365-70. 2.Saif MW. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer. 2005 Nov; 5 ( 4): 247-56. 3.Gualdrini UA, Sambuelli A, Barugel M, et al. Prevention of colorectal cancer. Acta Gastroenterol Latinoam 2005; 35 (2): 104-40. 4.Giovannucci E, Willett WC. Dietary factors and risk of colon cancer. Ann Med. 1994 Dec; 26(6): 443-52. 5.Benito M, Diaz -Rubio E. Molecular biology in colorectal cancer. Clin Transl Oncol. 2006 Jun; 8 (6): 391-8. 6.Gonzalez CA. Nutrition and cancer: the current epidemiological evidence. Br J Nutr. 2006 Aug; 96 Suppl V.S42-5. 7.Palmer S. Diet, nutrition and cancer. Prog Food Nutr Sci. 1985;9(3-4 ): 283-341. 8.Martinez ME. Primary prevention of colorectal cancer: lifestyle,nutrition, exercise. Recent Results Cancer Res. 2005; 166:177-211. 9.Jemal A, Siegel E, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin.2006 Mar-Apr 56(2): 106-30. 10.Hawk E, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin North Am. 2002 Oct; 82(5): 905-41. 11.Eckhauser FE, Knol JA. Surgery for primary and metastatic colorectal cancer. Gastroenterol Clin.North Am. 1997 Mar; 26(1): 103-28. 12.Lamberti C, Sauerbruch T. Early diagnosis of colorectal tumors. Internist (Beri). 2005 Apr; 4684): 401-10. 13.Dunlop MG. Polyps and carcinoma. In: Shearman DJC, Finlayson NC, Camileri MEds. Disease of the Gastrointestinal Tract and Liver. 3rdEd. 1399-1448.
  2. Churchill Livingstone, Newyork, 1997. 14.Singh KK, Barry MK, Ralston P, et al. Audit of colorectal cancer surgery by nonspecialist surgeons. Br J Surg, 1997:84:343-347. 15.Burcharth F, Jensen BV. Treatment of liver and lung metasta-ses from colorectal cancer Ugeskr Laeger. 2005 Nov 7; 167(45): 4268-72. 16.Faivre J, Manfredi S, Bouvier AM.Epidemiology of colorectal cancer liver metastases Bull Acad Natl Med. 2003; 187(5): 815-22. 17.Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg. 1999 Feb,86 (2): 158-69. 18.Kasper HU, Drebber U, Dries V.et al. Liver metastases: incidence and histogenesis Z Gastroenterol. 2005 Oct; 43(10):1149-57. 19.Kornek GV, Scheithauer W. Follow-up investigations in colorectal cancer. Onkologie 2003 Jun; 26(3). 303-7. 20.Steele G Jr. Follow-up plans after treatment of primary colon and rectal cancer. WorldJ Surg. 2001; 15.583. 21.Langevin JM, Rothenberger DA, Goldbe